<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01932606</url>
  </required_header>
  <id_info>
    <org_study_id>13-004077</org_study_id>
    <nct_id>NCT01932606</nct_id>
  </id_info>
  <brief_title>Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction</brief_title>
  <official_title>Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barry Borlaug</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure with preserved ejection fraction (HFpEF) is a major public health problem that
      has no proven effective treatment. This study assessed the effects of acute nitrite
      administration on resting and exercise hemodynamics in patients with HFpEF.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects were studied on their long-term medications in the post-absorptive state and supine
      position. Right heart catheterization was performed with simultaneous expired gas analysis at
      rest and during supine exercise at a 20 Watts workload for 5 minutes. After the first
      exercise phase (before any drug administration) and after return to steady-state baseline
      hemodynamic values, subjects were randomized. Study drug or placebo was infused for 5
      minutes. After a 10 minute observation period, hemodynamic measurements were repeated at
      rest, followed by repeat supine exercise at a 20 Watts workload for 5 minutes, identical to
      the study's first phase. Arterial and venous blood samples and hemodynamic and expired gas
      data were acquired during each stage of the protocol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise Pulmonary Capillary Wedge Pressure (PCWP)</measure>
    <time_frame>during repeat exercise run, approximately 30 minutes after study drug administration</time_frame>
    <description>Pulmonary capillary wedge pressure (PCWP) provides an indirect estimate of left atrial pressure (LAP). PCWP is the pressure measured by wedging a pulmonary catheter with an inflated balloon into a small pulmonary arterial branch.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Central Pressures After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood Pressure After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pulmonary Vascular Resistance (PVR) After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pulmonary Artery (PA) Compliance After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systemic Vascular Resistance (SVR) After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Left Ventricular Stroke Work (LVSW) After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oxygen Consumption (VO_2) After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Arteriovenous Oxygen Content Difference After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Output After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) The volume of blood pumped per minute by each ventricle of the heart. Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stroke Volume After Study Drug (Resting)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Central Pressures After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood Pressure After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PVR After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in PA Compliance After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SVR After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in LVSW After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oxygen Consumption (VO_2) After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Arteriovenous Oxygen Difference After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cardiac Output After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stroke Volume After Study Drug (Exercise)</measure>
    <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
    <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Heart Disease</condition>
  <condition>Heart Failure With Preserved Ejection Fraction</condition>
  <condition>Exercise Intolerance</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Nitrite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitrite</intervention_name>
    <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
    <arm_group_label>Nitrite</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline Placebo for Nitrite</intervention_name>
    <description>Normal saline placebo will be infused for 5 minutes during the cardiac catheterization procedure. Hemodynamics will then be measured at baseline after study drug infusion and again during low level exercise (20 Watts).</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo a cardiac catheterization procedure.

          -  Clinical symptoms of shortness of breath and fatigue

          -  Normal left ventricular ejection fraction (≥50%)

          -  Elevated left ventricular filling pressures at cardiac catheterization (defined as
             resting pulmonary capillary wedge pressure (PCWP)&gt;15 mmHg and/or PCWP≥25 mmHg during
             exercise)

        Exclusion Criteria:

          -  Systolic BP &lt;120 mmHg

          -  Prior nitrate therapy (within previous 2 weeks)

          -  Glucose 6-phosphate dehydrogenase (G6PD) deficiency

          -  Other &quot;non-HFpEF&quot; specific causes of heart failure such as significant valvular
             disease (&gt;moderate left-sided regurgitation, &gt;mild stenosis), severe pulmonary
             disease, unstable coronary disease or coronary spasm, primary renal or hepatic
             disease, constrictive pericarditis, or infiltrative, restrictive, or hypertrophic
             cardiomyopathies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barry Borlaug, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Borlaug BA, Koepp KE, Melenovsky V. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2015 Oct 13;66(15):1672-82. doi: 10.1016/j.jacc.2015.07.067.</citation>
    <PMID>26449137</PMID>
  </results_reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2013</study_first_submitted>
  <study_first_submitted_qc>August 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2013</study_first_posted>
  <results_first_submitted>January 15, 2016</results_first_submitted>
  <results_first_submitted_qc>January 18, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 15, 2016</results_first_posted>
  <last_update_submitted>February 15, 2016</last_update_submitted>
  <last_update_submitted_qc>February 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Barry Borlaug</investigator_full_name>
    <investigator_title>M.D., Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were enrolled in the trial between January and September 2014.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Nitrite</title>
          <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nitrite</title>
          <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
            <count group_id="B2" value="14"/>
            <count group_id="B3" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69" spread="6"/>
                    <measurement group_id="B2" value="70" spread="8"/>
                    <measurement group_id="B3" value="69" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Exercise Pulmonary Capillary Wedge Pressure (PCWP)</title>
        <description>Pulmonary capillary wedge pressure (PCWP) provides an indirect estimate of left atrial pressure (LAP). PCWP is the pressure measured by wedging a pulmonary catheter with an inflated balloon into a small pulmonary arterial branch.</description>
        <time_frame>during repeat exercise run, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Exercise Pulmonary Capillary Wedge Pressure (PCWP)</title>
          <description>Pulmonary capillary wedge pressure (PCWP) provides an indirect estimate of left atrial pressure (LAP). PCWP is the pressure measured by wedging a pulmonary catheter with an inflated balloon into a small pulmonary arterial branch.</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.0" spread="5.0"/>
                    <measurement group_id="O2" value="28.0" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0003</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Pressures After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Pressures After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right atrial pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" spread="2"/>
                    <measurement group_id="O2" value="0" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pulmonary artery systolic pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8" spread="5"/>
                    <measurement group_id="O2" value="-3" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean pulmonary artery pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6" spread="3"/>
                    <measurement group_id="O2" value="-1" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCWP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3" spread="3"/>
                    <measurement group_id="O2" value="0" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in right atrial pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0003</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in pulmonary artery systolic pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in mean pulmonary artery pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the 2 arms for change in PCWP.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Heart Rate After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Heart Rate After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
          <units>beats/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="5"/>
                    <measurement group_id="O2" value="-3" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.15</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Blood Pressure After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Blood Pressure After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7" spread="8"/>
                    <measurement group_id="O2" value="-2" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3" spread="4"/>
                    <measurement group_id="O2" value="-1" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in systolic blood pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.11</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in mean blood pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pulmonary Vascular Resistance (PVR) After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pulmonary Vascular Resistance (PVR) After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.</description>
          <units>mm Hg/L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="0.4"/>
                    <measurement group_id="O2" value="-0.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in PVR.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.7</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pulmonary Artery (PA) Compliance After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pulmonary Artery (PA) Compliance After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.</description>
          <units>ml/mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="1.3"/>
                    <measurement group_id="O2" value="0.2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in pulmonary artery compliance.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Systemic Vascular Resistance (SVR) After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Systemic Vascular Resistance (SVR) After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.</description>
          <units>dyne/s * cm^5</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140" spread="350"/>
                    <measurement group_id="O2" value="20" spread="160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in SVR.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Left Ventricular Stroke Work (LVSW) After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Left Ventricular Stroke Work (LVSW) After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.</description>
          <units>g/beat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6" spread="18"/>
                    <measurement group_id="O2" value="0" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in LVSW.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Oxygen Consumption (VO_2) After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Oxygen Consumption (VO_2) After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.)</description>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" spread="38"/>
                    <measurement group_id="O2" value="-6" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in VO_2.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Arteriovenous Oxygen Content Difference After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Arteriovenous Oxygen Content Difference After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.</description>
          <units>ml/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.5"/>
                    <measurement group_id="O2" value="0" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for arteriovenous oxygen content difference.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Cardiac Output After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) The volume of blood pumped per minute by each ventricle of the heart. Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cardiac Output After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) The volume of blood pumped per minute by each ventricle of the heart. Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.8"/>
                    <measurement group_id="O2" value="-0.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in cardiac output.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Stroke Volume After Study Drug (Resting)</title>
        <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Stroke Volume After Study Drug (Resting)</title>
          <description>Values are resting values after receiving study drug minus resting values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5" spread="16"/>
                    <measurement group_id="O2" value="-1" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in stroke volume.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Central Pressures After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Central Pressures After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right atrial pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5" spread="2"/>
                    <measurement group_id="O2" value="-1" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pulmonary artery systolic pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11" spread="6"/>
                    <measurement group_id="O2" value="-4" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean pulmonary artery pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="4"/>
                    <measurement group_id="O2" value="-2" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PCWP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11" spread="5"/>
                    <measurement group_id="O2" value="-2" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in right atrial pressure (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in pulmonary artery systolic pressure (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.01</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in mean pulmonary artery pressure (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in PCWP (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Heart Rate After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Heart Rate After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
          <units>beats/minute</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" spread="6"/>
                    <measurement group_id="O2" value="0" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in heart rate.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Blood Pressure After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Blood Pressure After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5" spread="13"/>
                    <measurement group_id="O2" value="2" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5" spread="8"/>
                    <measurement group_id="O2" value="0" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in systolic blood pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in diastolic blood pressure.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in PVR After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in PVR After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary Vascular Resistance (PVR) is the resistance to flow that must be overcome to push blood through the pulmonary vasculature. Acute and chronic lung disease can both cause an increase in PVR. Chronic PVR can lead to right sided heart failure.</description>
          <units>mm Hg/L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0.4"/>
                    <measurement group_id="O2" value="0.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in PVR after study drug (exercise)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in PA Compliance After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in PA Compliance After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Pulmonary artery compliance is an index of the elasticity of the blood vessel, an indication of arterial stiffness.</description>
          <units>ml/mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.9"/>
                    <measurement group_id="O2" value="0.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in PA compliance after study drug (exercise)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.3</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in SVR After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in SVR After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Systemic vascular resistance (SVR) refers to the resistance to blood flow offered by all of the systemic vasculature, excluding the pulmonary vasculature.</description>
          <units>dyne/s * cm^5</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-70" spread="140"/>
                    <measurement group_id="O2" value="70" spread="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in SVR after study drug (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in LVSW After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in LVSW After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke work refers to the work done by the ventricle to eject a volume of blood (i.e., stroke volume) into the aorta. Ventricular stroke work can be estimated as the product of stroke volume and mean aortic pressure during ejection.</description>
          <units>g/beat</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" spread="12"/>
                    <measurement group_id="O2" value="-2" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in LVSW after study drug (exercise)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0003</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Oxygen Consumption (VO_2) After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Oxygen Consumption (VO_2) After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.)</description>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" spread="138"/>
                    <measurement group_id="O2" value="-30" spread="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in oxygen consumption (VO_2) after study drug (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Arteriovenous Oxygen Difference After Study Drug (Exercise)</title>
        <description>Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Arteriovenous Oxygen Difference After Study Drug (Exercise)</title>
          <description>Arteriovenous oxygen difference is the difference in the oxygen content of the blood between the arterial blood and the venous blood. It is an indication of how much oxygen is removed from the blood in capillaries as the blood circulates in the body.</description>
          <units>ml/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.4"/>
                    <measurement group_id="O2" value="0" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in arteriovenous oxygen difference after study drug (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Cardiac Output After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cardiac Output After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Cardiac output is equal to the stroke volume (the amount of blood pumped from a ventricle in a single heartbeat) times the heart rate.</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.7"/>
                    <measurement group_id="O2" value="-0.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in cardiac output after study drug (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Stroke Volume After Study Drug (Exercise)</title>
        <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.</description>
        <time_frame>baseline, approximately 30 minutes after study drug administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nitrite</title>
            <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Stroke Volume After Study Drug (Exercise)</title>
          <description>Values are exercise values after receiving study drug minus exercise values before study drug (on the same day.) Stroke volume is the amount of blood pumped out of the heart (left ventricle - to the body) during each contraction.</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="8"/>
                    <measurement group_id="O2" value="-5" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between the arms for change in stroke volume after study drug (exercise).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Subjects will be followed for adverse event reporting during the procedure and the recovery period, approximately 3 hours after the procedure on Day 1.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Nitrite</title>
          <description>Study drug (NaNO_2 50 mcg/kg/min) will be infused for 5 minutes during the cardiac catheterization procedure.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Saline Placebo for Nitrite will be infused for 5 minutes during the cardiac catheterization procedure.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Barry A. Borlaug</name_or_title>
      <organization>Mayo Clinic</organization>
      <phone>507-284-6704</phone>
      <email>Borlaug.Barry@mayo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

